Statistics

Total Visits

Views
Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial(legacy) 161
Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial(legacy) 64

Total Visits per Month

November 2023 December 2023 January 2024 February 2024 March 2024 April 2024 May 2024
Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial 5 3 1 1 1 5 4

File Downloads

Views

Top Country Views

Views
United States 47
China 22
Australia 20
Netherlands 8
Vietnam 5
Germany 3
France 3
Finland 2
Argentina 1
Singapore 1

Top City Views

Views
Kaleen 19
Beijing 17
Ashburn 15
Rotterdam 8
Des Moines 6
Fairfield 5
Hanoi 5
Boardman 3
Cambridge 3
Helsinki 2